BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2017 3:54:00 PM | Browse: 347 | Download: 280
Publication Name World Journal of Hepatology
Manuscript ID 30000
Country of Manuscript Source Italy
2016-09-03 09:36
Peer-Review Started
2016-09-03 20:06
To Make the First Decision
2016-10-20 09:20
Return for Revision
2016-10-24 15:14
2016-10-26 00:33
Second Decision
2016-11-10 14:26
Accepted by Journal Editor-in-Chief
2016-11-10 17:39
Accepted by Company Editor-in-Chief
2016-12-02 10:37
Articles in Press
2016-12-02 10:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
2016-12-15 05:58
Typeset the Manuscript
2017-03-01 12:39
Publish the Manuscript Online
2017-03-06 15:54
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
Manuscript Source Invited Manuscript
All Author List Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili and Antonio Gasbarrini
Funding Agency and Grant Number
Correspondence To Cecilia Binda, MD, Internal Medicine, Gastroenterology and Hepatology, Catholic University Sacred Heart of Rome, Agostino Gemelli Hospital, Largo Agostino Gemelli 8, 00168 Rome, Italy. cecilia.binda@gmail.com
Keywords Direct acting antivirals; Hepatitis C; Liver transplantation; Liver fibrosis; Cirrhosis; Hepatocellular carcinoma
Core Tip The approval of new direct acting antivirals with high rates of virological clearance and excellent tolerability has dramatically improved hepatitis C virus (HCV) infection curability, especially for patients with advanced liver disease and for liver transplant recipients. The aim of this review is to draw the possible future scenery in HCV-related liver disease, focusing our attention on the impact of second generation direct acting antivirals on liver fibrosis, hepatocellular carcinoma and liver transplantation.
Publish Date 2017-03-06 15:54
Citation Ponziani FR, Mangiola F, Binda C, Zocco MA, Siciliano M, Grieco A, Rapaccini GL, Pompili M, Gasbarrini A. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol 2017; 9(7): 352-367
Url http://www.wjgnet.com/1948-5182/full/v9/i7/352.htm
DOI http://dx.doi.org/10.4254/wjh.v9.i7.352
Full Article (PDF) WJH-9-352.pdf
Full Article (Word) WJH-9-352.doc
Revised Manuscript 30000-Review.docx
Peer-review Report 30000-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 30000-Journal editor-in-chief review report.pdf
Answering Reviewers 30000-Answering reviewers.pdf
Scientific Misconduct Check 30000-Scientific misconduct check.pdf
Scientific Editor Work List 30000-Scientific editor work list.pdf
Audio Core Tip 30000-Audio core tip.aiff
Conflict-of-Interest Disclosure Form 30000-Conflict-of-interest statement.pdf
Copyright License Agreement 30000-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 30000-Language certificate.pdf